Skip to content

Observation and Research on the Clinical Effect of Oliceridine Fumarate Injection in General Anesthesia

Observation and Research on the Clinical Effect of Oliceridine Fumarate Injection in General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105523
Enrollment
Unknown
Registered
2025-07-04
Start date
2025-08-08
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group S:The use of sufentanil during general anesthesia
Group O:The use of oxysemitide during general anesthesia

Sponsors

Sir Run Run Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 85 years old; 2. ASA classification I to III; 3. Patients undergoing elective general anesthesia; 4. Willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy to the experimental drug; 2. General anesthesia contraindications; 3. Patients with heart, lung, liver, kidney, blood and other important system diseases; 4. Patients with communication or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Blood pressure;Heart rate;Blood oxygen saturation;Vasoactive drugs and narcotic drugs dosage;

Secondary

MeasureTime frame
BIS;PACU residence time;Duration of anesthesia;Duration of operation;Postoperative delirium;Nausea and vomiting;NRS score;Postoperative adverse reaction;Postoperative recovery quality;Blood test indicators;

Countries

China

Contacts

Public ContactZhang Xiaojing

Sir Run Run Hospital Affiliated to Nanjing Medical University

1079136203@qq.com+86 151 9589 2614

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 7, 2026